NO155863B - INSTALLATION FOR A PATIENT TO PROVIDE AN OBJECT WITHIN A SURVEY AREA. - Google Patents
INSTALLATION FOR A PATIENT TO PROVIDE AN OBJECT WITHIN A SURVEY AREA. Download PDFInfo
- Publication number
- NO155863B NO155863B NO82821921A NO821921A NO155863B NO 155863 B NO155863 B NO 155863B NO 82821921 A NO82821921 A NO 82821921A NO 821921 A NO821921 A NO 821921A NO 155863 B NO155863 B NO 155863B
- Authority
- NO
- Norway
- Prior art keywords
- acid
- frequency
- frequencies
- isoxazole
- formula
- Prior art date
Links
- 238000009434 installation Methods 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 17
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 150000002545 isoxazoles Chemical class 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- HHDGXHAOLVKSNQ-UHFFFAOYSA-N 5-(hydroxymethyl)-1,2-oxazol-3-one Chemical compound OCC1=CC(O)=NO1 HHDGXHAOLVKSNQ-UHFFFAOYSA-N 0.000 claims description 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical class C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 abstract 4
- 238000001514 detection method Methods 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 239000004065 semiconductor Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 54
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 14
- ZJQHPWUVQPJPQT-UHFFFAOYSA-N muscimol Chemical compound NCC1=CC(=O)NO1 ZJQHPWUVQPJPQT-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- -1 azidomethyl compound Chemical class 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000003610 charcoal Substances 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- LCFSQWLCIUITOH-UHFFFAOYSA-N (3-bromo-1,2-oxazol-5-yl)methanamine Chemical compound NCC1=CC(Br)=NO1 LCFSQWLCIUITOH-UHFFFAOYSA-N 0.000 description 3
- DAYPJEWQEJIWDR-UHFFFAOYSA-N 4-amino-1,2-oxazol-3-one Chemical compound NC1=CON=C1O DAYPJEWQEJIWDR-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 235000019445 benzyl alcohol Nutrition 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- GOYVQDNFGMZJNQ-UHFFFAOYSA-N (3-chloro-1,2-oxazol-5-yl)methanol Chemical compound OCC1=CC(Cl)=NO1 GOYVQDNFGMZJNQ-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DIIVXOUBNHJXED-UHFFFAOYSA-N (3-methoxy-1,2-oxazol-5-yl)methanol Chemical compound COC=1C=C(CO)ON=1 DIIVXOUBNHJXED-UHFFFAOYSA-N 0.000 description 1
- MBTTWUDVHGZSIF-UHFFFAOYSA-N (3-phenylmethoxy-1,2-oxazol-5-yl)methanamine Chemical compound O1C(CN)=CC(OCC=2C=CC=CC=2)=N1 MBTTWUDVHGZSIF-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RHFWLPWDOYJEAL-UHFFFAOYSA-N 1,2-oxazol-3-amine Chemical compound NC=1C=CON=1 RHFWLPWDOYJEAL-UHFFFAOYSA-N 0.000 description 1
- NFCHMZFEFOKVDT-UHFFFAOYSA-N 3-bromo-5-(bromomethyl)-1,2-oxazole Chemical compound BrCC1=CC(Br)=NO1 NFCHMZFEFOKVDT-UHFFFAOYSA-N 0.000 description 1
- ABSRTUPJGPVCBM-UHFFFAOYSA-N 5-(azidomethyl)-1,2-oxazol-3-one Chemical compound OC1=NOC(=C1)CN=[N+]=[N-] ABSRTUPJGPVCBM-UHFFFAOYSA-N 0.000 description 1
- DZYGNTRDQYBNTF-UHFFFAOYSA-N 5-(chloromethyl)-1,2-oxazol-3-one Chemical compound ClCC1=CC(=O)NO1 DZYGNTRDQYBNTF-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 238000006418 Brown reaction Methods 0.000 description 1
- OTRODFZMYWXKBT-UHFFFAOYSA-N COC(C(C(=O)O)O)(C)OC Chemical compound COC(C(C(=O)O)O)(C)OC OTRODFZMYWXKBT-UHFFFAOYSA-N 0.000 description 1
- RGBAVYYUSCMHOA-UHFFFAOYSA-N COC1=NOC(=C1C)N Chemical compound COC1=NOC(=C1C)N RGBAVYYUSCMHOA-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XQMNCACMRJJYEN-UHFFFAOYSA-N N-[(3-phenylmethoxy-1,2-oxazol-5-yl)methyl]acetamide Chemical compound C(C1=CC=CC=C1)OC1=NOC(=C1)CNC(C)=O XQMNCACMRJJYEN-UHFFFAOYSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- PKKVTWZUWVHYHY-UHFFFAOYSA-N NCC1=CC(=NO1)O.OC1=NOC(=C1C)N Chemical compound NCC1=CC(=NO1)O.OC1=NOC(=C1C)N PKKVTWZUWVHYHY-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 206010007776 catatonia Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940089960 chloroacetate Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- AKPQKVAXDWKQIB-UHFFFAOYSA-N ethyl 2,2-dimethoxybutanoate Chemical compound CCOC(=O)C(CC)(OC)OC AKPQKVAXDWKQIB-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002506 high-vacuum sublimation Methods 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229940116315 oxalic acid Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000007978 oxazole derivatives Chemical class 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Landscapes
- Burglar Alarm Systems (AREA)
Abstract
erkeorgan (34) for sikring mot tyveri og som omfatter en halvlederdiode forbundet med en metallantennesløyfe (38), er ut-formet for å motta to adskilte radiofrekvensutstrålinger.Dioden (36) danner bro og en lukket sløyfe ved den ene ende av antennen (38), og frembringer derved en tankkrets med resonansfrekvens lik det dobbelte av en valgt senterfrekvens. En første sender (26) frembringer en tonemodulert radiofrekvens (f) for-skjøvet til den ene side av senterfrekvensen, mens en annen sender (30) frembringer en kontinuerlig radiobølge med frekvens (f> forskjøvet til den annen side av senterfrekvensen. Begge signaler tilføres adskilt til hvert sitt sett av dipolutstrål-ende antennestrimler (18, 19, 20, 21) på motstående sider av et overvåkningsområde. Dipolstrimlene for de forskjellige frekvenser er anordnet i rett vinkel med hverandre på hver side av overvåkningsområdet, mens dipolstrimlene for samme frekvens står vinkelrett på hverandre på hver sin side av området. En sådan antenneanordning frembringer krysspolarisert utstråling av begge frekvenser i overvåkningsområdet. Dioden (36) i merkeorganet (34) blander de to'frekvenser som mottas av antenne-sløyfen (38), og bringer tankkretsen til resonans ved summen av de to frekvenser (det dobbelte av senterfrekvensen). Denne i LZ! resonansfrekvens gjenutstråles til mottagerantenner (22, 24) ^ på hver sin side av overvåkningsområdet for deteksjon i en meget smalbåndet mottager (42) som reagerer på summen av de to frekvenser. Modulasjonstonen utledes så fra det mottatte signal og bringes til å utløse en alarm (44) når det detekterte signal er av tilstrekkelig styrke og varighet.The anti-theft means (34) comprising a semiconductor diode connected to a metal antenna loop (38) is configured to receive two separate radio frequency radiators. The diode (36) forms a bridge and a closed loop at one end of the antenna (38). ), thereby producing a tank circuit with a resonant frequency equal to twice that of a selected center frequency. A first transmitter (26) produces a tone modulated radio frequency (f) shifted to one side of the center frequency, while a second transmitter (30) produces a continuous radio wave having a frequency (f> shifted to the other side of the center frequency. separate dipole beam antenna strips (18, 19, 20, 21) on opposite sides of a monitoring area The dipole strips for the different frequencies are arranged at right angles to each other on each side of the monitoring area, while the dipole strips for the same frequency stand Such an antenna device produces cross-polarized radiation of both frequencies in the monitoring area, the diode (36) in the marking means (34) mixes the two frequencies received by the antenna loop (38), and brings the tank circuit to resonance at the sum of the two frequencies (twice the center frequency) This in LZ! resonance frequency is re-radiated to receiving antennas (22, 24) ^ on either side of the monitoring area for detection in a very narrowband receiver (42) which responds to the sum of the two frequencies. The modulation tone is then derived from the received signal and caused to trigger an alarm (44) when the detected signal is of sufficient strength and duration.
Description
Fremgangsmåte for fremstilling av et hittil ukjent, terapeutisk virksomt isoxazolderivat. Process for the production of a hitherto unknown, therapeutically active isoxazole derivative.
Nærværende oppfinnelse vedrører en The present invention relates to a
fremgangsmåte 'for fremstilling av et hittil ukjent isoxazolderivat, som innehar verdi-fulle farmakologiske egenskaper. Det ble overraskende funnet at det hittil ikke kjente 3-hydroxy-5-aminomethyl-isoxazol med formel I, method for the production of a hitherto unknown isoxazole derivative, which possesses valuable pharmacological properties. It was surprisingly found that the hitherto unknown 3-hydroxy-5-aminomethyl-isoxazole of formula I,
såvel, som dets syreaddisjonssalter allerede i meget små doser virker hemmende på sentral-nervesystemet. I særdeleshet lar en meget sterk potensering av virkningen av nakotika såvel som en nedsettelse av motiliteten, katatone og sedative virknin-ger, hemming av tremorintremor og anti-metisk virkning seg konstatere. Ror fremstilling av 3-hydroxy-5-ami-nomethyl-isoxazol med formel I hydrerer eller reduserer man en forbindelse med den generelle formel II as well as its acid addition salts already in very small doses have an inhibitory effect on the central nervous system. In particular, a very strong potentiation of the effect of narcotics as well as a reduction of motility, catatonic and sedative effects, inhibition of tremor intremor and antiemetic effect can be noted. For the preparation of 3-hydroxy-5-aminomethyl-isoxazole of formula I, one hydrates or reduces a compound of the general formula II
hvor R betyr' hydrogen eller toenzylgruppen. where R means' hydrogen or the toenzyl group.
Hydreringen av en forbindelse med den generelle formel II kan gjennomføres f. eks. i nærvær av palladium på kull eller av Raney-nikkel, som katalysatorer i et organisk oppløsningsmiddel, som dioxan, ethanol, methanol eller tetrahydrofuran ved værelsetemperatur. Forbindelsen med formel I faller ut ved hydrering, som zwit-terion og er dermed i stor utstrekning unndratt den videre innvirkning av 'hydrogen. Forurensninger og biprodukter er opp-løselige i organiske oppløsningsmidler, hvorfor det er mrulig å renonsere på rens-ningen av den til hydrering anvendte azi-domethylforbindelse. The hydrogenation of a compound with the general formula II can be carried out, e.g. in the presence of palladium on charcoal or of Raney nickel, as catalysts in an organic solvent, such as dioxane, ethanol, methanol or tetrahydrofuran at room temperature. The compound of formula I precipitates upon hydrogenation as a zwitterion and is thus to a large extent exempt from the further influence of hydrogen. Contaminants and by-products are soluble in organic solvents, which is why it is difficult to renounce the purification of the azidomethyl compound used for hydration.
Azidomethylforbindelsene med den generelle formel II oppnås f. eks. ved omset-ning av en réaksjonsdyktig ester av 3-alkoxy-5-hydroxy-methyl-isoxazol med natriumazid i et egnet organisk oppløs-ningsmiddel, som f. eks. aceton, ved værelsetemperatur eller svakt forhøyet temperatur. The azidomethyl compounds of the general formula II are obtained, e.g. by reacting a reactive ester of 3-alkoxy-5-hydroxy-methyl-isoxazole with sodium azide in a suitable organic solvent, such as e.g. acetone, at room temperature or slightly elevated temperature.
Videre oppnår man forbindelsen med formel I idet man hydrogenolyserer en 'forbindelse med formel III, Furthermore, the compound of formula I is obtained by hydrogenolyzing a compound of formula III,
hvor R' betyr benzylgruppen, og overfører 3-hydroxy-5-aminomethyl-isoxazolet, hvis ønsket, til et salt med en uorganisk eller organisk syre. Hydrogenolysen kan finne sted samtidig, dvs. i samme arbeidsgang, med en hydrering ifølge den ovenfor be-skrevne fremstillingsfremgangsmåte. Videre når man til 3-hydroxy-5-amino-methyl-isoxazol med formel I, idet man behandler en forbindelse med iformel IV, where R' means the benzyl group, and transfers the 3-hydroxy-5-aminomethyl-isoxazole, if desired, to a salt with an inorganic or organic acid. The hydrogenolysis can take place simultaneously, i.e. in the same work process, with a hydration according to the above-described production method. Furthermore, 3-hydroxy-5-amino-methyl-isoxazole of formula I is reached, by treating a compound with formula IV,
i. in.
hvor R" betyr en lavere alkylrest eller benzylgruppen, med bromhydrogensyre, klorhydrogensyre eller med hydrokloridet eller hydrobromidet av eventuelt alkylsubstitu-ert pyridin i varme, f. eks. ved temperatu-rer mellom ca. 100° og 150°. where R" means a lower alkyl residue or the benzyl group, with hydrobromic acid, chlorohydrochloric acid or with the hydrochloride or hydrobromide of any alkyl-substituted pyridine in heat, for example at temperatures between about 100° and 150°.
Til utgangsforbindelser med formel III og IV, hvor R' og R" betyr benzylgruppen, når man på i og for seg kjent måte, idet f. eks. 3-:brom-5-aminomethylisoxazol oppvarmes med benzylalkohol i nærvær av alkalihydroxyd i noen timer. Forbindelsene med formel IV, hvor R" betyr en lavere alkylrest, oppnår man på i og for seg kjent måte ved oppvarmning av en lavere alkanol med 3-brom-5-aminomethylisoxazol i nærvær av alkalihydroxyd. To the starting compounds of formula III and IV, where R' and R" mean the benzyl group, when in a manner known per se, e.g. 3-:bromo-5-aminomethylisoxazole is heated with benzyl alcohol in the presence of alkali hydroxide for a few hours The compounds of formula IV, where R" denotes a lower alkyl residue, are obtained in a manner known per se by heating a lower alkanol with 3-bromo-5-aminomethylisoxazole in the presence of alkali hydroxide.
En ytterligere 'fremgangsmåte for fremstilling av det nye isoxazolderivat med formel I toestår i at man omsetter en reaktiv ester av 3-hydroxy-5-hydroxymethyl-isoxazol med formel V A further method for producing the new isoxazole derivative of formula I involves reacting a reactive ester of 3-hydroxy-5-hydroxymethyl-isoxazole with formula V
med ammoniakk. with ammonia.
Omsetningen finner sted fortrinnsvis i et lukket kar. The turnover preferably takes place in a closed vessel.
Som reaktive estere av forbindelser As reactive esters of compounds
med formel V egner seg i særdeleshet halo-genider, som klor, brom eller jod såvel som svovelsyreestere, <f. eks. estere av tolylsul-fonsyre, av p-bromsultfonsyre eller av me-thylsulfonsyre. with formula V are particularly suitable halogenides, such as chlorine, bromine or iodine as well as sulfuric acid esters, <f. e.g. esters of tolylsulfonic acid, of p-bromosulfonic acid or of methylsulfonic acid.
Forbindelsen med formel V oppløses i en lavere alkanol eller i vann, mettes i kul-de med tørr ammoniakk og oppbevares så i noen timer ved øket temperatur i lukket kar. Et 3-hydroxy-5-halogenmethyl-isoxazol méd formel V oppnår man f. eks. fra y-halogen-p,|3-dimethoxy-hydroxamsmør-syre ved behandling med klorhydrogensyre. Tilslutt når man til nye oxazolderivater med formel I, idet man hydrolyserer en forbindelse med den generelle formel VI, The compound of formula V is dissolved in a lower alkanol or in water, saturated in the cold with dry ammonia and then stored for a few hours at an elevated temperature in a closed vessel. A 3-hydroxy-5-halomethyl-isoxazole with formula V is obtained, e.g. from y-halo-p,|3-dimethoxy-hydroxambutyric acid by treatment with hydrochloric acid. Finally, new oxazole derivatives of formula I are reached by hydrolyzing a compound of the general formula VI,
hvor Ac betyr en laveremolekylær acylrest. Hydrolysen finner sted fortrinnsvis ved behandling av forbindelsen med den generelle formel VI med saltsyre ved koketem-peratur. Som lavmolekylære acylrester. kommer f. eks. acethyl- eller benzoylresten på tale. .Til forbindelser med den generelle formel VI når man f. eks. ved hydrering av 3-benzyloxy-5-acylaminomethyl-isoxazolen ved hjelp av katalytisk aktivert hydrogen ved værelsetemperatur. where Ac means a lower molecular weight acyl residue. The hydrolysis preferably takes place by treating the compound of the general formula VI with hydrochloric acid at boiling temperature. As low molecular weight acyl residues. comes e.g. the acethyl or benzoyl residue in question. .For compounds with the general formula VI when e.g. by hydrogenation of 3-benzyloxy-5-acylaminomethyl-isoxazole using catalytically activated hydrogen at room temperature.
Hvis ønsket overføres det nye isoxazol- . derivat med 'formel I med uorganiske og organiske syrer, som saltsyre, bromhydrogensyre, svovelsyre, (fosforsyre, methansul-fonsyre, ethandisulfonsyre, |3-hydroxy-ethansulfonsyre, eddiksyre, melkesyre, oxalsyre, ■ ravsyre, fumarsyre, maleinsyre, eplesyre, vinsyre, sitronsyre, benzoesyre, salicylsyre, fenyleddiksyre og mandelsyre, til et salt. If desired, the new isoxazole is transferred. derivative of formula I with inorganic and organic acids, such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, methanesulfonic acid, ethanedisulfonic acid, 3-hydroxyethanesulfonic acid, acetic acid, lactic acid, oxalic acid, succinic acid, fumaric acid, maleic acid, malic acid, tartaric acid , citric acid, benzoic acid, salicylic acid, phenylacetic acid and mandelic acid, to a salt.
De ef ter følgende eksempler redegjør nærmere for gjennomføringen av frem-gangsmåten ifølge oppfinnelsen. Tempera-turene er angitt i Celsiusgrader. The following examples explain in more detail the implementation of the method according to the invention. The temperature ranges are indicated in degrees Celsius.
Eksempel 1. Example 1.
a) g -av blandingen av 3-klor-5-hydroxymethyl-isoxazol-<(3-klor-5-isoxazol-methanol) og 3-klor-5-[tetrahydropyran-(2')-oxymethyl]-isoxazol, fremstilt ifølge Gazz. chim. ital. 91, 47 (1961), og 80 g (ca. 400 pst. av den beregnede mengde) kaliumhydroxyd oppløses i 500 ml methanol og oppvarmes i 24 timer i autoklav véd 100— 110°. Den mørke metanoloppløsning avde-kanteres fra utfeldt salt og inndampes i vakuum. Resten og saltet oppløses sammen i 400 ml vann, oppløsningen innstilles surt med konsentrert saltsyre og ekstraheres i et 500 ml Kutscher-Steudel-apparat i 5 timer med ether. Etheroppløsningen tørkes over magnesiumsulfat og inndampes. Resten destilleres under 0,001 torr ved 60—90°. Halogenprøve negativ. NMR-spektret stem-mer på strukturen av 3-methoxy-5-hyd-roxy-methyl-isoxazol, viser imidlertid at ved siden av 5-hydroxymethyl-forbindelsen er 25 pst. 5-tetrahydropyranyloxymethyl-forbindelse tilstede. a) g -from the mixture of 3-chloro-5-hydroxymethyl-isoxazole-<(3-chloro-5-isoxazole-methanol) and 3-chloro-5-[tetrahydropyran-(2')-oxymethyl]-isoxazole, prepared according to Gazz. chim. Italian 91, 47 (1961), and 80 g (approx. 400 per cent of the calculated amount) of potassium hydroxide are dissolved in 500 ml of methanol and heated for 24 hours in an autoclave at 100-110°. The dark methanol solution is decanted from the precipitated salt and evaporated in vacuo. The residue and the salt are dissolved together in 400 ml of water, the solution is made acidic with concentrated hydrochloric acid and extracted in a 500 ml Kutscher-Steudel apparatus for 5 hours with ether. The ether solution is dried over magnesium sulfate and evaporated. The residue is distilled below 0.001 torr at 60-90°. Halogen test negative. The NMR spectrum is consistent with the structure of 3-methoxy-5-hydroxymethyl-isoxazole, however, shows that next to the 5-hydroxymethyl compound, 25% of the 5-tetrahydropyranyloxymethyl compound is present.
b) 30 g av den efter a) erholdte blanding røres i 300 ml absolutt benzol med 15 b) 30 g of the mixture obtained after a) is stirred in 300 ml of absolute benzene with 15
ml fosfortribromid 16 timer ved 30 til 40°. Reaksjonsblandingen vaskes to ganger med 300 ml isvann og en gang med 300 ml met-tet natriumkloridoppløsning, tørkes over natriumsulfat og inndampes. Ved destilla-sjon under 12 torr går 3-methoxy-5-brom-methyl-isoxazol over ved 102—104° C. Strukturbevis ved NMR-spektrum. ml of phosphorus tribromide 16 hours at 30 to 40°. The reaction mixture is washed twice with 300 ml of ice water and once with 300 ml of saturated sodium chloride solution, dried over sodium sulphate and evaporated. When distilled below 12 torr, 3-methoxy-5-bromo-methyl-isoxazole passes over at 102-104° C. Structural evidence by NMR spectrum.
c) 19,2 g (0,1 mol) av det ovenfor nevn-te bromid, oppløst i 150 ml aceton, tilsettes c) 19.2 g (0.1 mol) of the above-mentioned bromide, dissolved in 150 ml of acetone, are added
til en oppløsning av 39 g (0,6 mol) natriumazid i 150 ml vann og røres 12 timer ved 30°. Efter fortynning med 250 ml vann ekstraheres blandingen 3 ganger hver gang med 200 ml ether. Etherekstraktene vaskes 2 ganger hver gang med 500 ml vann, tør-kes over magnesiumsulfat og inndampes under vakuum ved 30°. 3-methoxy-5-azido-methyl-isoxazol, hvilket spalter seg eks-plosjonslignende ved 200°, blir tilbake, som en lysegul væske i kvantitativt utbytte. Strukturbevis ved NMR- + IR-spektrum. to a solution of 39 g (0.6 mol) of sodium azide in 150 ml of water and stirred for 12 hours at 30°. After dilution with 250 ml of water, the mixture is extracted 3 times each time with 200 ml of ether. The ether extracts are washed twice each time with 500 ml of water, dried over magnesium sulphate and evaporated under vacuum at 30°. 3-Methoxy-5-azido-methyl-isoxazole, which splits explosively at 200°, remains as a pale yellow liquid in quantitative yield. Evidence of structure by NMR + IR spectrum.
d) 5 g (32 mol) av produktet fra c) oppvarmes med 10 g (87 mol) pyridin-hydroklorid 22 timer under nitrogen ved 120°. Efter av-kjølning oppløses reaksjonsblandingen i 100 ml vann og tilsettes 10 ml konsentrert natronlut, hvoretter den alkaliske oppløs-ningen ekstraheres 2 ganger hver gang med 200 ml ether. Den organiske fase skilles fra, vaskes med 300 ml vann og fortynnet saltsyre, tørkes over magnesiumsulfat og inndampes, hvorved 15 pst. av det anvendte utgangsmaterial vinnes tilbake. Den vandige fase, en mørk, alkalisk oppløsning, innstilles kongosur med konsentrert saltsyre og ekstraheres i Kutscher-Steudel-apparat 6 timer med ether. Etheroppløsnin-gen tørkes over magnesiumsulfat og inndampes, resten oppløses i 50 ml absolutt ether og befris for få uoppløste flak ved behandling med aktiv-kull. Efter avdestil-lasjon av etheren ved 30° under forminsket trykk blir 3-hydroxy-5-azidomethyl-isoxazol tilbake i form av lys grønne krystaller med smeltepunkt 78—80°. d) 5 g (32 mol) of the product from c) are heated with 10 g (87 mol) pyridine hydrochloride for 22 hours under nitrogen at 120°. After cooling, the reaction mixture is dissolved in 100 ml of water and 10 ml of concentrated caustic soda is added, after which the alkaline solution is extracted twice each time with 200 ml of ether. The organic phase is separated, washed with 300 ml of water and dilute hydrochloric acid, dried over magnesium sulphate and evaporated, whereby 15 per cent of the starting material used is recovered. The aqueous phase, a dark, alkaline solution, is adjusted to Congo acid with concentrated hydrochloric acid and extracted in a Kutscher-Steudel apparatus for 6 hours with ether. The ether solution is dried over magnesium sulphate and evaporated, the residue is dissolved in 50 ml of absolute ether and freed from a few undissolved flakes by treatment with activated carbon. After distillation of the ether at 30° under reduced pressure, 3-hydroxy-5-azidomethyl-isoxazole is returned in the form of light green crystals with a melting point of 78-80°.
e) 6,7 g (48 mmol) av produktet fra d) oppløses i 140 ml absolutt dioxan, tilsettes e) Dissolve 6.7 g (48 mmol) of the product from d) in 140 ml absolute dioxane, add
6 g 5 pst.ig palladiumkull og behandles 3 timer ved 25° over normaltrykk med hydrogen. Katalysatoren filtreres ifra, vaskes med lite dioxan og oppslemmes flere ganger med vann. Den således erholdte oppløsning inndampes, resten oppløses i lite vann og klares med aktivkull. Den ved inndamp- 6 g of 5 pst.ig palladium charcoal and treated for 3 hours at 25° above normal pressure with hydrogen. The catalyst is filtered off, washed with a little dioxane and slurried several times with water. The solution thus obtained is evaporated, the remainder is dissolved in a little water and clarified with activated charcoal. The by evaporating
ningen av den klare oppløsningen erholdte rest røres i 50 ml methanol en time, hvorved det smørrete biprodukt løser seg og 3-hydroxy-5-aminomethyl-isoxazol blir tilbake krystallint. Det spaltes ved 155°. Ved forsiktig omkrystallisasjon fra vann og tetrahydrofuran oppnår man hvite krystaller med spaltningspunkt 175°. The residue obtained from the clear solution is stirred in 50 ml of methanol for one hour, whereby the buttery by-product dissolves and 3-hydroxy-5-aminomethyl-isoxazole becomes crystalline again. It splits at 155°. By careful recrystallization from water and tetrahydrofuran, white crystals with a cleavage point of 175° are obtained.
Eksempel 2. Example 2.
a) Man blander 600 ml ethanol og 600 ml tekn. kons. vandig ammoniakkoppløs-ning og metter det hele ved værelsetemperatur med ammoniakk. Til denne blanding drypper man ved værelsetemperatur 120,5 g (0,5 mol) 3-brom-5-brommethyl-isoxazol og lar oppløsningen, som litt efter litt blir mørkere, henstå i 24 timer. Derefter inndampes reaksjonsoppløsningen i vakuum til ca. 0,5 liter og innstilles surt med a) Mix 600 ml of ethanol and 600 ml of technical conc. aqueous ammonia solution and saturates it all at room temperature with ammonia. To this mixture, 120.5 g (0.5 mol) of 3-bromo-5-bromomethyl-isoxazole are added drop by drop at room temperature and the solution, which gradually darkens, is allowed to stand for 24 hours. The reaction solution is then evaporated in vacuo to approx. 0.5 liter and set sour with
2-n. saltsyre. De harpiksaktige biprodukter 2-n. hydrochloric acid. The resinous byproducts
fjernes ved filtrering med hyflo og kull. is removed by filtering with hyflo and charcoal.
Filtratet vaskes 2 ganger med kloroform eller methylenklorid og innstilles så alkalisk for frisetning av det basiske reaksjons-produkt med kons. natronlut. Heretter ekstraheres det fem ganger med kloroform eller methylenklorid. De forente ekstrakter tørkes over kaliumcarbonat og inndampes i vakuum. Den tilbakeblivende væske opp-løses i ether og eventuelt tilstedeværende smørelse eller blakking fjernes ved filtrering med kull. Det efter avdampning av etheren tilbakeblivende 3-br.om-5-amino-methyl-isoxazol er en lys 'brun væske og kan omsettes uten ytterligere rensning. The filtrate is washed twice with chloroform or methylene chloride and then made alkaline to release the basic reaction product with conc. baking soda. It is then extracted five times with chloroform or methylene chloride. The combined extracts are dried over potassium carbonate and evaporated in vacuo. The remaining liquid is dissolved in ether and any smearing or clouding present is removed by filtering with charcoal. The 3-br.om-5-amino-methyl-isoxazole remaining after evaporation of the ether is a light brown liquid and can be reacted without further purification.
b) 140 g kaliumhydroxyd (0,2 mol) oppløses i 885 ml methanol, 88,5 g (0,5 mol) b) 140 g potassium hydroxide (0.2 mol) is dissolved in 885 ml methanol, 88.5 g (0.5 mol)
rå 3-brom-5-aminomethyl-isoxazol tilsettes og kokes 20—30 timer under tilbakeløp. Efter avkjølning f raf Utreres kaliumbromid og harpiksaktige deler ved hyflo, det klare methanoliske filtrat inndampes, resten tas opp i ca. 0,5 1 vann og ekstraheres flere ganger med kloroform. De forente ekstrakter tørkes over kaliumcarbonat og inndampes. Destillasjonen av resten gir ved 0,01 torr og ca. 70° ca. 50—60 pst. av den teoret-isk beregnede mengde av reaksjonsproduktet. Den farveløse væske inneholder imidlertid efter NMR-spekteret ved siden av det ønskede 3-methoxy-5-amino-methyl-isoxazol ennu 20 pst. utgangsmaterial. raw 3-bromo-5-aminomethyl-isoxazole is added and boiled for 20-30 hours under reflux. After cooling, the potassium bromide and resinous parts are removed by hyflo, the clear methanolic filtrate is evaporated, the residue is taken up for approx. 0.5 1 water and extracted several times with chloroform. The combined extracts are dried over potassium carbonate and evaporated. The distillation of the residue gives at 0.01 torr and approx. 70° approx. 50-60 per cent of the theoretically calculated quantity of the reaction product. However, according to the NMR spectrum, the colorless liquid contains, next to the desired 3-methoxy-5-amino-methyl-isoxazole, another 20 percent starting material.
c) 65 g av reaksjonsproduktet fra b) kokes med 650 ml 24 pst.ig saltsyre 4 timer c) 65 g of the reaction product from b) is boiled with 650 ml of 24% hydrochloric acid for 4 hours
under tilbakeløp. Derefter ifortynnes reak-sjonsoppløsningen med det like volum vann og filtreres med kull gjennom hyflo. Den lysgule oppløsning inndampes i vakuum, resten tørkes, oppløses i 650 ml methanol og tilsettes 65 ml triethylamin. Den during reflux. The reaction solution is then diluted with the same volume of water and filtered with charcoal through hyflo. The pale yellow solution is evaporated in vacuo, the residue is dried, dissolved in 650 ml of methanol and 65 ml of triethylamine is added. It
tydelig alkaliske blanding inndampes i vakuum, resten oppslemmes i 650 ml frisk methanol, 325 ml tetrahydrofuran tilsettes og det hele avkjøles i kjøleskap. Det utfeld-te 3-hydroxy-5-aminomethyl-isoxazol (5-aminomethyl-3-isoxazol) vaskes først med methanol og derefter med ether. clearly alkaline mixture is evaporated in vacuo, the residue is suspended in 650 ml of fresh methanol, 325 ml of tetrahydrofuran is added and the whole is cooled in a refrigerator. The precipitated 3-hydroxy-5-aminomethyl-isoxazole (5-aminomethyl-3-isoxazole) is washed first with methanol and then with ether.
For fullstendig rensning oppløses sub-stansen i ca. den tyvedobbelte mengde vann, oppløsningen tilsettes methanol og filtreres en til to -ganger med kull gj ennom hyflo. Til det farveløse filtrat tilsettes ved værelsetemperatur tetrahydrofuran inntil begynnende krystallisasjon. Efter henstand ved værelsetemperatur frafiltreres sub-stansen. Efter flere dagers tørkning ved 12 torr over fosforpentoxyd i eksikator er den analyseren og smelter under spaltning ved 175° C. For complete purification, the substance is dissolved in approx. the twenty-fold amount of water, methanol is added to the solution and filtered once or twice with charcoal through hyflo. Tetrahydrofuran is added to the colorless filtrate at room temperature until crystallization begins. After standing at room temperature, the substance is filtered off. After drying for several days at 12 torr over phosphorus pentoxide in a desiccator, it is analyzed and melts during cleavage at 175° C.
Eksempel 3. Example 3.
a) 8,80 g (50 millimol) 3-brom-5-aminomethyl-isoxazol, 5,6 g (100 millimol) a) 8.80 g (50 millimoles) of 3-bromo-5-aminomethyl-isoxazole, 5.6 g (100 millimoles)
kaliumhydroxyd og 110 ml benzylalkohol oppvarmes i 10 timer ved 180°. Efter av-kjølning til 20° tilsettes reaksjonsblandingen den femdobbelte mengde ether og ekstraheres to ganger hver gang med 200 ml 2 n saltsyre. Det sure vandige ekstrakt vaskes 4 ganger hver gang med 300 ml ether, innstilles alkalisk og ekstraheres tilslutt tre ganger med methylenklorid. Efter tørkning av de forente methylenkloridekstrakter over magnesiumsulfat og avdestillering av oppløsningsmidlet oppnår man en gul olje, som ved kjerneresonansspektrum entydig kan identifiseres, som en blanding av 95 pst. 3-benzyloxy-5-amino-methyl-isoxazol og 5 pst. benzylalkohol. b) 1,02 g (5 millimol) 3-benzyloxy-5-aminomethyl-isoxazol hydreres i 50 ml abs. potassium hydroxide and 110 ml of benzyl alcohol are heated for 10 hours at 180°. After cooling to 20°, the fivefold amount of ether is added to the reaction mixture and extracted twice each time with 200 ml of 2 N hydrochloric acid. The acidic aqueous extract is washed 4 times each time with 300 ml of ether, made alkaline and finally extracted three times with methylene chloride. After drying the combined methylene chloride extracts over magnesium sulfate and distilling off the solvent, a yellow oil is obtained, which can be unequivocally identified by nuclear resonance spectrum as a mixture of 95% 3-benzyloxy-5-amino-methyl-isoxazole and 5% benzyl alcohol. b) 1.02 g (5 millimoles) of 3-benzyloxy-5-aminomethyl-isoxazole are hydrated in 50 ml abs.
dioxan i nærvær av palladium-kull-kata-lysator (5 pst.ig) ved normaltrykk og værelsetemperatur sålenge inntil 80 pst. av deri beregnede ekvimolare mengde hydrogen er opptatt. Derpå filtreres reaksjonsblandingen, filtergodset vaskes med abs. dioxan og oppslemmes tilslutt i 20 ml vann, hvorved reaksjonsproduktet går i oppløs-ning. dioxane in the presence of palladium-charcoal catalyst (5 per cent) at normal pressure and room temperature as long as up to 80 per cent of the equimolar amount of hydrogen calculated therein is taken up. The reaction mixture is then filtered, the filter material is washed with abs. dioxane and finally slurried in 20 ml of water, whereby the reaction product dissolves.
Efter frafiltrering av katalysatoren inndampes den vandige oppløsning. Resten består av rent 3-hydroxy-5-amino-methyl-isoxazol (5-aminomethyl-3-isoxazolol) med smeltepunkt 175° (under spaltning). After filtering off the catalyst, the aqueous solution is evaporated. The remainder consists of pure 3-hydroxy-5-amino-methyl-isoxazole (5-aminomethyl-3-isoxazolol) with a melting point of 175° (under decomposition).
Eksempel 4. Example 4.
a) 2,7 ml abs. methanol mettes ved 0° C med tørr saltsyregass. Dertil tilsettes a) 2.7 ml abs. methanol is saturated at 0° C with dry hydrochloric acid gas. Added to that
en blanding av 10,0 g y-kloraceteddikester a mixture of 10.0 g of γ-chloroacetate diester
(fremstilt efter. C. D. Hurd & J. L. Aber-nethy, J. Amer. Chem. Soc. 62, 1147 (1940)),' 20,0 g orthomaursyremethylester og 13 g abs. methanol. Blandingen kokes under vannutelukkelse fire timer under tilbake-løp. Den ennu varme reaksjonsblanding heller man under røring i 200 ml isvann, innstiller med 30 pst. natronlut straks på pH 8 og ekstraherer fire ganger med ether. Etherekstraktet tørkes over magnesiumsulfat. Efter avdampning av etheren utvin-ner man den tilbakeblivende olje i en 5 cm Vigreuxkolonne en ved 11 torr mellom 101° og 103° kokende hovedf r aksjon, hvilken ik-ke reagerer med vandig FeCls-oppløsning. (prepared after C. D. Hurd & J. L. Abernethy, J. Amer. Chem. Soc. 62, 1147 (1940)),' 20.0 g of orthoformic acid methyl ester and 13 g of abs. methanol. The mixture is boiled under water exclusion for four hours under reflux. The still warm reaction mixture is poured into 200 ml of ice water while stirring, immediately adjusted to pH 8 with 30% caustic soda and extracted four times with ether. The ether extract is dried over magnesium sulfate. After evaporation of the ether, the remaining oil is extracted in a 5 cm Vigreux column, a main fraction boiling between 101° and 103° at 11 torr, which does not react with aqueous FeCls solution.
■b) En oppløsning av 35,0 g hydroxyl-aminhydroklorid (0,5 mol) i 210 ml varm abs. methanol avkjøles kort i isbad og tilsettes under røring i nitrogenatmosfære så en oppløsning av 42 g kaliumhydroxyd ■b) A solution of 35.0 g of hydroxylamine hydrochloride (0.5 mol) in 210 ml of hot abs. methanol is cooled briefly in an ice bath and added while stirring in a nitrogen atmosphere to a solution of 42 g of potassium hydroxide
(0,75 mol) i 155 ml methanol, slik at tem-peraturen Æor reaksjonsoppløsriingen ikke stiger over 20° C. Efter avsluttet alkalitil-setning røres det videre i 5 'minutter i isba-det, derefter avsuges blandingen gjennom et glassfilter og nutsj godset eftervaskes med lite methanol. Til filtratet tilsettes straks en oppløsning av 35,9 g y-klor-|3,p-. dimethoxy-smørsyreethylester i 20 ml methanol og står til henstand under nitrogen 96 timer ved værelsetemperatur. Efter no-en timer finner en liten krystallutskillelse (0.75 mol) in 155 ml of methanol, so that the temperature during the reaction dissolution does not rise above 20° C. After the addition of alkali is finished, it is stirred for 5 minutes in the ice bath, then the mixture is filtered off with suction through a glass filter and the goods are washed with a little methanol. A solution of 35.9 g of y-chloro-|3,p- is immediately added to the filtrate. dimethoxy-butyric acid ethyl ester in 20 ml of methanol and allowed to stand under nitrogen for 96 hours at room temperature. After a few hours a small crystal discharge is found
(KC1) sted. Reaksjonsoppløsningen inndampes i vakuum. Resten oppløses i den dobbelte mengde vann og spaltes på en anione-utvekslersøyle (Dowex <®>). Søylen nøytralvaskes med vann, elueres derefter med 2n eddiksyre. Ved spissen av syresonen 'uttrer eluatet kort alkalisk, mot slutten av denne alkaliske fraksjon blir FeCl;!-prøven positiv (vinrød). (KC1) place. The reaction solution is evaporated in vacuo. The residue is dissolved in twice the amount of water and separated on an anion exchange column (Dowex <®>). The column is neutral washed with water, then eluted with 2N acetic acid. At the tip of the acid zone, the eluate appears briefly alkaline, towards the end of this alkaline fraction the FeCl;! sample becomes positive (wine red).
Det FeCl8-positive eluat oppfanges og inndampes i vakuum ved 40°. Den lysgule krystalline rest avdampes 5 ganger med vann inntil eddiksyre*rihet i vakuum, tør-kes derefter ved 40 pst., 5 torr i 15 timer. Det erholdte lysegule produkt er fullstendig oppløselig i abs. methanol og smelter ved 107—110°. The FeCl8-positive eluate is collected and evaporated in vacuum at 40°. The pale yellow crystalline residue is evaporated 5 times with water until acetic acid purity in vacuum, then dried at 40%, 5 torr for 15 hours. The light yellow product obtained is completely soluble in abs. methanol and melts at 107—110°.
Til analyse omkrystalliseres tre ganger fra aceton, derpå sublimeres ved 120°/10-<3 >torr i kulerør. Det hvite sublimat har et smeltepunkt på 129—131°; sintrer fra 124°. For analysis, recrystallize three times from acetone, then sublimate at 120°/10-<3 >torr in a ball tube. The white sublimate has a melting point of 129—131°; sinters from 124°.
c) 5,0 g rå y-klor-|3,|5 dimethoxy-hyd-roxamsmørsyre 1 130 ml iseddik mettes under magnetrøring først ved værelsetemperatur,. så ved 0° med tørr HC1 og står derefter til henstand ved værelsetemperatur i 16 timer. Den lysbrune oppløsning inndampes ved 40° i vakuum og resten fordampes 3 ganger med vann. Det således erholdte gule krystalline produkt ekstraheres varmt to ganger hver gang med 130 ml ether, den gule etheroppløsning filtreres og inndampes, hvorpå lys gule nåler med smeltepunkt 90—95° blir tilbake. Det ennu ikke helt rene produkt er ustabilt. En rensning kan oppnås ved 'forsiktig omkrystallisasjon fra tetraklorkarbon eller aceton eller ved høy-vakuumsublimasjon (i små porsjoner). Renproduktet er vesentlig stabilere: hvite nåler med smeltepunkt 97—101° (sintrer fra ca. 80°). Sterk sur reaksjon i vandig oppløsning. c) 5.0 g raw y-chloro-|3,|5 dimethoxy-hydroxy-butyric acid 1 130 ml glacial acetic acid is saturated under magnetic stirring first at room temperature. then at 0° with dry HC1 and then allowed to stand at room temperature for 16 hours. The light brown solution is evaporated at 40° in vacuum and the residue is evaporated 3 times with water. The yellow crystalline product thus obtained is extracted hot twice each time with 130 ml of ether, the yellow ether solution is filtered and evaporated, after which light yellow needles with a melting point of 90-95° remain. The still not completely pure product is unstable. A purification can be achieved by 'careful recrystallization from carbon tetrachloride or acetone or by high-vacuum sublimation (in small portions). The pure product is significantly more stable: white needles with a melting point of 97-101° (sinters from about 80°). Strong acid reaction in aqueous solution.
d) En oppløsning av 3,1 g rå hydroxy-5-klormethylisoxazol i 40 ml abs. methanol d) A solution of 3.1 g of crude hydroxy-5-chloromethylisoxazole in 40 ml of abs. methanol
mettes i en trykkautoklav med glassinnsats ved 0° C med tørr ammoniakk, stenges inne og holdes så 10 timer ved 100°. Den danne-de mørke brune reaksjonsoppløsning inndampes i vakuum, resten taes opp i vann og filtreres. Filtratet spaltes på en ione-ut-vekslersøyle (Dowex <®> ). Man eluerer med vann inntil et ifarveløst nøytralt kloridfritt filtrat oppnås. Det søkte aminoisoxazolol blir 'fullstendig på søylen og elueres med 2 pst. ammoniakkoppløsning. (Prøvning- av eluatet ved papirelektroforese). Den aminoisoxazolol inneholdende fraksjon reagerer også efter fullstendig fjerning av am-moniakken alkalisk (pH 8). Aminoisoxa-zololet lar seg utvaske med vann. Efter inndampning av den aminoisoxazolol inneholdende fraksjon blir gule krystaller tilbake: Omkrystallisasjon fra vann methanol gir 3-hydroxy-5-amino-methyl-isoxazol med smeltepunkt 175° (under spaltning). saturated in a pressure autoclave with a glass insert at 0° C with dry ammonia, sealed and then kept for 10 hours at 100°. The dark brown reaction solution formed is evaporated in vacuo, the residue is taken up in water and filtered. The filtrate is separated on an ion-exchange column (Dowex <®> ). Elute with water until a colorless neutral chloride-free filtrate is obtained. The desired aminoisoxazolol is completely deposited on the column and is eluted with a 2% ammonia solution. (Testing of the eluate by paper electrophoresis). The aminoisoxazolol-containing fraction also reacts alkaline (pH 8) after complete removal of the ammonia. Aminoisoxazolol can be washed out with water. After evaporation of the fraction containing aminoisoxazol, yellow crystals remain: Recrystallization from water methanol gives 3-hydroxy-5-amino-methyl-isoxazole with melting point 175° (under decomposition).
Eksempel 5. Example 5.
a) 6,80 g (33 mmol) 3-benzyloxy-5-amino-methylisoxazol oppvarmes i 19 ml a) 6.80 g (33 mmol) of 3-benzyloxy-5-amino-methylisoxazole are heated in 19 ml
(200 mmol) eddiksyreanhydæid og 100 ml iseddik 15 timer ipå et dampbad. Efter til-setning av 100 ml methanol kokes en time under tilbakeløp og inndampes. Resten opptas i 100 ml kloroform, vaskes med 2n. natriumbicarbonatoppløsning, vann, 2n. saltsyre og igjen med vann og tørkes over magnesiumsulfat. Efter inndampning oppnår man krystaller, som smelter efter omkrystallisasjon ifra ether/pentan ved 73— 76°. (200 mmol) acetic anhydride and 100 ml glacial acetic acid for 15 hours in a steam bath. After adding 100 ml of methanol, boil for one hour under reflux and evaporate. The residue is taken up in 100 ml of chloroform, washed with 2n. sodium bicarbonate solution, water, 2n. hydrochloric acid and again with water and dried over magnesium sulphate. After evaporation, crystals are obtained, which melt after recrystallization from ether/pentane at 73-76°.
b) 492 mg (2 mmol) 3-benzyloxy-5-acethylaminomethyl-isoxazol hydreres i 10 b) 492 mg (2 mmol) of 3-benzyloxy-5-acetylaminomethyl-isoxazole is hydrated in 10
ml 95 pst.ig ethanol eller iseddik over ifor-hydrert 10 pst.ig palladium/kull ved normaltrykk og 20° i 6 minutter under opptag-else av 2 millimol hydrogen. Efter frafilt- ml of 95% ethanol or glacial acetic acid over pre-hydrated 10% palladium/coal at normal pressure and 20° for 6 minutes while absorbing 2 millimoles of hydrogen. After defil-
rering av katalysatoren oppnår man ved inndampning 3-hydroxy-5-acethylamino-methyl-isoxazol, smletepunkt 132—135°. by evaporation of the catalyst, 3-hydroxy-5-acetylamino-methyl-isoxazole is obtained, melting point 132-135°.
c) 312 mg (2 mmol) 3-hydroxy-acet-aminomethyl-isoxazol oppvarmes i 20 ml c) 312 mg (2 mmol) of 3-hydroxy-acet-aminomethyl-isoxazole is heated in 20 ml
2n. saltsyre i 2y2 time under tilbakeløp. Efter inndampning og to timers tørkning over fast kalilut ved 50° og 0,1 torr oppnår man 3-hydroxy-5-amino-methyl-isoxazol-hydroklorid, smeltepunkt 160° (spaltning). 2n. hydrochloric acid for 2y2 hours under reflux. After evaporation and drying for two hours over solid potassium hydroxide at 50° and 0.1 torr, 3-hydroxy-5-amino-methyl-isoxazole hydrochloride is obtained, melting point 160° (decomposition).
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19557280A | 1980-10-09 | 1980-10-09 | |
PCT/US1981/001335 WO1982001437A1 (en) | 1980-10-09 | 1981-10-01 | Dual frequency anti-theft system |
Publications (3)
Publication Number | Publication Date |
---|---|
NO821921L NO821921L (en) | 1982-06-09 |
NO155863B true NO155863B (en) | 1987-03-02 |
NO155863C NO155863C (en) | 1987-06-10 |
Family
ID=26764895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO821921A NO155863C (en) | 1980-10-09 | 1982-06-09 | INSTALLATION FOR A PATIENT TO PROVIDE AN OBJECT WITHIN A SURVEY AREA. |
Country Status (2)
Country | Link |
---|---|
MC (1) | MC1497A1 (en) |
NO (1) | NO155863C (en) |
-
1981
- 1981-10-01 MC MC81US8101335D patent/MC1497A1/en unknown
-
1982
- 1982-06-09 NO NO821921A patent/NO155863C/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO821921L (en) | 1982-06-09 |
NO155863C (en) | 1987-06-10 |
MC1497A1 (en) | 1983-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3242190A (en) | 3-hydroxy-5-aminomethylisoxazole compounds | |
SU776557A3 (en) | Method of preparing optically active anthracyclinones | |
SU578870A3 (en) | Method of preparing n-(methoxymethyl)furilmethyl-6,7-benzomorphanes or morhinanes or their salts | |
NO134417B (en) | ||
CN112679420A (en) | Preparation method of 2,5-dibromopyridine | |
NO155863B (en) | INSTALLATION FOR A PATIENT TO PROVIDE AN OBJECT WITHIN A SURVEY AREA. | |
WO2023178814A1 (en) | Method for preparing intermediate of paxlovid | |
NO151387B (en) | SETTING DEVICE FOR AN ELECTRONIC DIGITAL INDICATOR | |
Kiang et al. | 268. The action of acyl cyanides on 2-and 1: 2-substituted indoles. Part II. Derivatives of 2-o-aminophenylindole | |
US3278600A (en) | alpha-amine-p-methoxyisobutyrophenone and salts thereof | |
NO115758B (en) | ||
NO149353B (en) | PROCEDURE FOR PREPARING 6-CHLORO-ALFA-METHYL CARBZOL-2-ACETIC ACID | |
US2701251A (en) | Process of producing indoleacetic acids and new indoleacetic acids produced thereby | |
NO137093B (en) | PROCEDURES FOR THE PREPARATION OF 2,4-DIAMINO-5-BENZYLPYRIMIDINES | |
US4025520A (en) | Dehydrohalogenation of a 7-halodihydrocodeinone dialkyl ketal | |
NO172689B (en) | PROCEDURE FOR THE PREPARATION OF TETRIC ACID AND 4-BENZYLOXY-3-PYRROLINE-2-ON USED IN THE PROCEDURE | |
NO140010B (en) | ANALOGICAL PROCEDURES FOR THE PREPARATION OF THERAPEUTIC ACTIVITIES 6-SUBSTITUTED 3-CARBETHOXYHYDRAZINOPYRIDAZINES | |
NO154669B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 10-BRAKE SANDWICIN AND 10-BROMISOSANDWICIN, AND ACID ADDITION SALTS THEREOF. | |
NO143154B (en) | PROCEDURE FOR THE PREPARATION OF SULFAMOYL BENZO ACIDS | |
SU656511A3 (en) | Method of obtaining derivatives of hexahydro-4-indolinole and salts thereof | |
SU418036A1 (en) | METHOD FOR OBTAINING DERIVATIVES OF 8H-PYRIMIDO- [5.4- &] [1,4] -OXAZINON-7 | |
SU239871A1 (en) | METHOD OF OBTAINING 2-ALKYL (BENZYL) -4-ALKYL (BENZYL | |
NO116631B (en) | ||
SU470110A3 (en) | The method of obtaining - (aminophenyl) aliphatic derivatives of carboxylic acids or their salts or their oxides | |
SU522187A1 (en) | The method of obtaining 3-acyl-2-alkyl (aryl) -imidazo (1,2) pyridines |